NAT10 and cancer: To study the impact of NAT10 on cancer cells, we knockdown both HeLa and MCF7 using NAT10 siRNA, which was confirmed using qRT‐PCR in transfected control (siC) versus NAT10 knockdown cells (siNAT10) (Figure 1C,D).